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Abstract 
P53 Overview 
P53, also known as the “The guardian of the genome”, was first described in 1979 as the first identified tumor suppressor gene. It is a crucial protein in cells, where 
regulates the cell cycle and it is important because of its role in conserving stability by preventing genome mutation.  
Our cells face many dangers, including chemicals, viruses and ionizing radiation. For instance, if key regulatory elements are damaged, the normal controls on cell 
growth may be blocked and the cell will rapidly multiply and grow into a tumor. p53 tumor suppressor is one of our defenses against this type of damage. 
It is normally found at low levels, but when DNA damage is sensed, its levels rise and it adopts its active tetramer conformation, and initiates protective measures acting 
as an “emergency brake”. p53 binds to many regulatory sites in the genome, acting as a transcription factor, and begins production of proteins that halt cell division 
until the damage is repaired. Or, if the damage is too severe, it initiates the process of apoptosis, which directs the cell to commit suicide, permanently removing the 
damage. 
Therefore,  the dissection of its apoptotic pathway it is of great importance to understand the key points of the mechanisms underlying in taking decisions and cell fate 
in order to design new cancer therapies.  
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The apoptotic pathway 
Different promotor affinities for P53 
 
- Growth arrest: P21 promotor ↑ affinity , activated at low levels 
- Apoptosis:  higher levels and extensive stress 
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Function 
Once activated, it acts as a transcriptional activator or 
transrepressor  of genes involved  in different  cellular 
processes such as angiogenesis, growth arrest, DNA repair 
and apoptosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Activation 
Stress and 
DNA damage 
Kinases 
(ATM,ATR..) 
phosphorryater 
P53 N-terminal  
Blocking of 
MDM2-P53 
interaction 
Increase of 
P53 Half-life 
and nuclear 
accumulation 
Tetramerization 
Active 
transcription 
factor 
P53 Half-life: 5-20min 
 
-Through its ubiquitin-ligase activity 
 
-Quenching p53 transcription activity by 
occluding the p53 transactivation domain 
 
P53 Shuttle from nucleus to cytoplasm 
for proteasome degradation 
MDM2-P53 Regulation 
Choice of response 
Apoptotic-related gene induction 
TARGET GENES:  those with P53 responsive elements 
INDUCED GENES FUNCTION 
BAX Mitochondrial pore protein 
PUMA Pro-apoptotic BH3 protein associated with 
Bcl2,  promote Cyt C release 
PERP Pro-apoptotic transmembrane protein 
NOXA Associated with Bcl2,  promote Cyt C 
release 
Bcl2 Anti-apoptotic BH3 protein 
PIGs Apoptosis by regulation of redox potential 
P53AIP Dissipate mitochondrial potential 
NF-KB Transcription factor, mediator of TNF 
receptor signaling  
FAS Death receptor, procaspase 9 activation 
FAS1/APO1 Death receptor ligand 
DR5/KILLER Death receptor 
IGF-BP3 IGF binding protein 3, anti-mitogenic and 
pro-apoptotic 
PIDD “P53-induced protein with death domain”, 
participates in death receptor signaling 
APAF1 Adaptor protein for caspase 9 activation 
HTRA2 Serine protease 
MDM2 P53 regulator, Ubiquitin-ligase 
MDM2 Inhibits p53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apoptosome and caspases 
 Death receptors  (TNF family) 
•FAS  
•DR5//Killer 
•PERP 
 
 
 
 
 
The Extrinsic pathway 
Recruit of 
adaptor 
proteins 
Caspase 
activation 
DISC 
The Intrinsic pathway 
 
 
 They can be activated  by: 
 
  tBid and Bim 
  Directly by p53 
 Being released from Bcl2,  which is an anti-
apoptotic protein that represses  Bax and 
Bak. When P53 is activated, it binds to Bcl2 
thereby allowing them to form the MOMP. 
 
Bcl2 Family 
MOMP 
Bax and Bak are membrane 
proteins of the outer 
mitochondrial membrane that 
regulate the membrane 
permeabilization (MOMP). 
When activated, they homo-
oligomerize and form the pore. 
MOMP formation allows the release of 
caspase activation molecules such as: 
 
 
•  Cytochrome C 
• SMAC/DIABLO 
• EndoG1 
Apoptosoma = Apaf-1+Cytochrome C + caspase 9 
Activation of 
effector 
caspases 
APOPTOSIS 
 
 
Role of PIGs and ROS 
Convenient apoptosis 
 
Plant meristems:  TED2  high homology with PIG3 :↑ ROS 
 
 Cancer therapy  control of P53, induce apoptosis in target cells  
   
 Nutlin:  small molecule that leadt to P53-MDM2 disruption 
 
 
  ROS are downstream mediators of apoptosis 
  Several P53 induced genes (PIGs) are related to oxidative stress  
 
PIG3  bioactivation of quinones  ROS production  apoptosis 
Polyak et al.  model: 
 
1. Transcription induction of 
REDOX related genes 
 
2. Formation of ROS 
 
3. Oxidative degradation of 
mitochondrial components 
culminating in cell death 
   
• P53 follows a complex regulation mechanism which enables the 
cell to respond accordingly with the extent of stress or damage. 
 
• MDM2, post translational modifications and its different 
structural domains, is what provides P53 with its accurate 
sensitivity.  
 
• The mitochondrial pore (MOMP) is under the regulation of a 
complex network of membrane proteins that are also 
transcriptionally regulated by P53.  
 
• PIG3 and ROS are important for the apoptosis followed by 
oxidative stress in response to P53.  
 
• P53 is a good candidate for cancer therapy. If we are able to 
control the induction of apoptosis, we could target and induce 
the apoptosis in cancer cells.  
 
 
 
  
Conclusion 
“Further understanding of the apoptotic 
pathway is without doubt a  crucial step 
towards the development of new cancer 
therapies” 
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